BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31470998)

  • 1. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
    Oporto Caroca JI; Oporto Caroca J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune retinopathy associated with colonic adenoma.
    Saito W; Kase S; Ohguro H; Ishida S
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1447-9. PubMed ID: 22886094
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
    Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
    Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.
    Bursztyn LL; Belrose JC; Coupland SG; Fraser JA; Proulx AA
    Retin Cases Brief Rep; 2015; 9(2):173-6. PubMed ID: 25764315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
    Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
    BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of serum anti-retinal antibodies in the Chinese patients with presumed autoimmune retinopathy.
    Zeng HY; Liu Q; Peng XY; Cao K; Jin SS; Xu K
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1759-1764. PubMed ID: 31119427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated retinopathy.
    Goldstein SM; Syed NA; Milam AH; Maguire AM; Lawton TJ; Nichols CW
    Arch Ophthalmol; 1999 Dec; 117(12):1641-5. PubMed ID: 10604671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe visual loss caused by autoimmune retinopathy].
    ten Berge JC; Schreurs MW; Dufour-van den Goorbergh BC; de Witte PM; van Schooneveld MJ; Rothova A
    Ned Tijdschr Geneeskd; 2015; 159():A8039. PubMed ID: 25654680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features of Japanese Patients With Anti-α-enolase Antibody-Positive Autoimmune Retinopathy: Novel Subtype of Multiple Drusen.
    Ando R; Saito W; Kanda A; Kase S; Fujinami K; Sugahara M; Nakamura Y; Eguchi S; Mori S; Noda K; Shinoda K; Ishida S
    Am J Ophthalmol; 2018 Dec; 196():181-196. PubMed ID: 30195891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
    Karatsai E; Robson AG; Taylor SRJ
    JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
    Guy J; Aptsiauri N
    Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretinal antibody- proven autoimmune retinopathy.
    Abraham S; Sudharshan S; Bhende M; Ganesh SK; Gopal S
    Indian J Ophthalmol; 2017 May; 65(5):416-420. PubMed ID: 28574003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase.
    Saito M; Saito W; Kanda A; Ohguro H; Ishida S
    BMC Ophthalmol; 2014 Jan; 14():5. PubMed ID: 24428923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune retinopathy in the absence of cancer.
    Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
    Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
    Saito W; Kase S; Yoshida K; Ohguro H; Yokoi M; Iwaki H; Ohno S
    Am J Ophthalmol; 2005 Nov; 140(5):942-5. PubMed ID: 16310487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated retinopathy associated with invasive thymoma.
    Katsuta H; Okada M; Nakauchi T; Takahashi Y; Yamao S; Uchida S
    Am J Ophthalmol; 2002 Sep; 134(3):383-9. PubMed ID: 12208250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presumed autoimmune retinopathy following chickenpox; a case report.
    Prime Z; Sims J; Danesh-Meyer H
    Int Ophthalmol; 2018 Oct; 38(5):2187-2190. PubMed ID: 28825165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.